214 related articles for article (PubMed ID: 6182405)
1. Studies on the mechanism of the acute antihypertensive and vasodilator actions of several beta-adrenoceptor antagonists.
Sybertz EJ; Baum T; Pula KK; Nelson S; Eynon E; Sabin C
J Cardiovasc Pharmacol; 1982; 4(5):749-58. PubMed ID: 6182405
[TBL] [Abstract][Full Text] [Related]
2. Comparison of prizidilol, a new antihypertensive drug with combined arteriolar vasodilator and beta-adrenoceptor blocking actions, with hydralazine and propranolol in conscious dogs with chronic atrioventricular block.
Boucher M; Dubray C; DuchĂȘne-Marullaz P
J Cardiovasc Pharmacol; 1983; 5(5):712-6. PubMed ID: 6195455
[TBL] [Abstract][Full Text] [Related]
3. Pharmacodynamic and pharmacokinetic studies on prizidilol and nipradilol (K-351), antihypertensive drugs with combined vasodilator and beta-adrenoceptor blocking actions, in rabbits.
Kawashima K; Watanabe TX; Sokabe H
Jpn J Pharmacol; 1984 Dec; 36(4):519-26. PubMed ID: 6151998
[TBL] [Abstract][Full Text] [Related]
4. Antihypertensive actions of an isomer of labetalol and other vasodilator-beta-adrenoceptor blockers.
Baum T; Sybertz EJ
Fed Proc; 1983 Feb; 42(2):176-81. PubMed ID: 6130003
[TBL] [Abstract][Full Text] [Related]
5. Comparison of prizidilol hydrochloride (SK & F 92657), a new antihypertensive agent with beta-adrenoceptor antagonist and vasodilator activity with propranolol and hydralazine in normal volunteers.
Steiner JA; Clancy A; Manghani KK; James IM
Br J Clin Pharmacol; 1981 Oct; 12(4):573-8. PubMed ID: 6117309
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological properties of the stereoisomers of prizidilol: their use in analysis of reflex tachycardia and blood pressure control in normotensive cats, rats, and dogs.
Owen DA; Eden RJ; Lamb MS; Taylor EM
J Cardiovasc Pharmacol; 1986; 8(4):743-8. PubMed ID: 2427813
[TBL] [Abstract][Full Text] [Related]
7. An assessment of beta-adrenoceptor blockade in man by prizidilol hydrochloride.
Pitcher DW; Curry PV; Trounce JR
Br J Clin Pharmacol; 1982 May; 13(5):711-6. PubMed ID: 6123343
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological studies of N-(2,5-dimethyl-1H-pyrrol-1-yl)-6-(4-morpholinyl)-3-pyridazinamine hydrochloride (MDL-899), a new long-acting antihypertensive vasodilator.
Baldoli E; Bianchi G; Corsico N; Di Francesco GF
Arzneimittelforschung; 1985; 35(5):818-26. PubMed ID: 2862874
[TBL] [Abstract][Full Text] [Related]
9. Acute effects of combined vasodilation and beta-adrenoceptor blockade with prizidilol on renal function.
Boehringer K; Weidmann P; Link L; Bianchetti MG; Schiffl H; Reubi FC
Br J Clin Pharmacol; 1983 Feb; 15(2):181-8. PubMed ID: 6133543
[TBL] [Abstract][Full Text] [Related]
10. Studies on the mechanism of arterial vasodilation produced by the novel antihypertensive agent, carvedilol.
Nichols AJ; Gellai M; Ruffolo RR
Fundam Clin Pharmacol; 1991; 5(1):25-38. PubMed ID: 1712335
[TBL] [Abstract][Full Text] [Related]
11. Acute effects of prizidilol on blood pressure, heart rate, catecholamines, renin and aldosterone in essential hypertension.
Bianchetti MG; Boehringer K; Weidmann P; Link L; Schiffl H; Ziegler WH
Eur J Clin Pharmacol; 1982 Oct; 23(4):289-96. PubMed ID: 6129141
[TBL] [Abstract][Full Text] [Related]
12. Studies on agents with vasodilator and beta-blocking activities. IV.
Seki T; Nakao T; Masuda T; Hasumi K; Gotanda K; Ishimori T; Honma S; Minami N; Shibata K; Yasuda K
Chem Pharm Bull (Tokyo); 1996 Nov; 44(11):2061-9. PubMed ID: 8945771
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary effects in man of oral prizidilol hydrochloride (SK&F 92657), a new antihypertensive agent.
Edmondstone WM; Waller JF; Manghani KK; Hill PL; Bell AJ; Denison DM
Br J Clin Pharmacol; 1983 Dec; 16(6):591-8. PubMed ID: 6140939
[TBL] [Abstract][Full Text] [Related]
14. Beta adrenoceptor blocking properties of MK-761.
Sweet CS; Hall RA; Columbo JM; Wenger HC; Backlund E; Morgan G; Gaul SL; Scriabine A
J Pharmacol Exp Ther; 1979 Oct; 211(1):195-9. PubMed ID: 40012
[TBL] [Abstract][Full Text] [Related]
15. Comparative actions of dihydropyridine slow channel calcium blocking agents in conscious dogs: systemic and coronary hemodynamics with and without combined beta adrenergic blockade.
Warltier DC; Zyvoloski MG; Gross GJ; Brooks HL
J Pharmacol Exp Ther; 1984 Aug; 230(2):367-75. PubMed ID: 6146711
[TBL] [Abstract][Full Text] [Related]
16. Hemodynamic profile of a new antihypertensive agent D,L-3-[2-(3-t-butylamino-2-hydroxypropoxy)phenyl]-6-hydrazinopyridazine (SK&F 92657).
Taylor EM; Cameron D; Eden RJ; Fielden R; Owen DA
J Cardiovasc Pharmacol; 1981; 3(2):337-54. PubMed ID: 6166805
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological studies on cadralazine: a new antihypertensive vasodilator drug.
Semeraro C; Dorigotti L; Banfi S; Carpi C
J Cardiovasc Pharmacol; 1981; 3(3):455-67. PubMed ID: 6168827
[TBL] [Abstract][Full Text] [Related]
18. [Acute tolerance to the hypotensive effect of pindolol in spontaneously hypertensive rats (SHR)].
Matsunaga K; Ueda M
Nihon Yakurigaku Zasshi; 1983 Oct; 82(4):259-66. PubMed ID: 6141128
[TBL] [Abstract][Full Text] [Related]
19. Beta-adrenoceptor blockade and vasodilatation in essential hypertension. Hemodynamic studies at rest and during exposure to stress.
Eggertsen R
Acta Med Scand Suppl; 1984; 689():1-46. PubMed ID: 6151343
[TBL] [Abstract][Full Text] [Related]
20. Analysis of hypotensive mechanisms of pindolol, a beta-adrenoceptor blocking drugs in rats.
Ozawa H; Matsubara T; Chen CS
Jpn J Pharmacol; 1977 Apr; 27(2):295-302. PubMed ID: 18631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]